Pharma Sources Insight June 2022: New Developments of COVID-19, Greater Impact on the Pharma Market
May 22, 2022
Pharma Sources Insight June 2022 focuses on new developments of COVID-19, and greater impacts it brings to the Pharma Market.
The Oral Vaccine Market and Technology
May 12, 2022
A vaccine is a biologic that improves immunity to disease. Vaccination is considered the most effective means of controlling infectious disease-related morbidity and mortality.
Where Are the Oral COVID-19 Vaccines Stand Now?
December 17, 2021
The novel coronavirus, SARS-CoV-2, has led to an unprecedented international health crisis and is continuing its spread across the world, with more than 218 million confirmed cases of COVID-19, including more than 4.5 million deaths, reported to the WHO a
Oravax Medical to test triple antigen oral vaccine against Omicron
December 03, 2021
Indian biotechnology firm Premas Biotech’s joint venture company Oravax Medical is set to begin testing their triple antigen oral vaccine candidate against the new Omicron variant of concern.
ICMR-NICED submits proposal to DBT for research on oral COVID-19 vaccine
July 06, 2021
It will take around five to six years to develop the oral vaccine in a laboratory, said Shanta Dutta, Director, ICMR-NICED.
Therapeutic proteins and oral vaccines market to surpass $300,000mn by 2027
February 19, 2021
The market is expected to grow at a 6.7 percent CAGR, driven by the increasing prevalence of cancer and cardiovascular diseases, as well as growing interest in biologics.
Oral COVID-19 vaccine candidate to enter Phase I human trials
September 17, 2020
Vaxart’s application for a Phase I clinical trial to evaluate its oral COVID-19 vaccine candidate has been cleared by the FDA.